Navigation Links
NeoTract Designates Dr. Tarek Pacha as UroLift® Center of Excellence
Date:6/25/2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Tarek Pacha, D.O., Memorial Heathcare in Owosso, MI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Pacha has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Tarek Pacha as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations

Media:
Nicole Osmer, 650.454.0504
nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Read the full story at https://www.prweb.com/releases/neotract_designates_dr_tarek_pacha_as_urolift_center_of_excellence/prweb17217651.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NeoTract Designates Dr. Kalpesh Patel as UroLift® Center of Excellence
2. NeoTract Designates Dr. Elizabeth Mobley as UroLift® Center of Excellence
3. NeoTract Designates Dr. Timothy Lesser as UroLift® Center of Excellence
4. NeoTract Designates Dr. Samuel Dakil as UroLift® Center of Excellence
5. NeoTract Designates Dr. Tony Nimeh as UroLift® Center of Excellence
6. NeoTract Designates Dr. T. Casey McCullough as UroLift® Center of Excellence
7. NeoTract Designates Dr. Patrick P. Daily as UroLift® Center of Excellence
8. NeoTract Designates Dr. Vi Hua as UroLift® Center of Excellence
9. NeoTract Designates Dr. Jayant Uberoi as UroLift® Center of Excellence
10. NeoTract Designates Dr. Adam Perzin as UroLift® Center of Excellence
11. NeoTract Designates Dr. Andrew Maes as UroLift® Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... Ariz. (PRWEB) , ... July 07, 2020 , ... ... providing emergency medical assistance to Navajo Nation residents, the 33 nonprofits who received ... communities worldwide. In its fourth round of funding, the foundation awarded grants totaling ...
(Date:7/2/2020)... , ... July 02, 2020 , ... AllenComm, the leader ... projects and four Omni Awards for visually compelling compliance training , onboarding ... to meet and exceed client and industry expectations as a digital transformation partner for ...
(Date:7/1/2020)... ... ... Dexur’s analysis of medicare claims of hospitals within a 25-mile radius of Cleveland, ... Center , and Lutheran Hospital had the best value outcomes ... a patient’s episode of care from the date of admission for 90 days and ...
Breaking Medicine Technology:
(Date:7/7/2020)... NEW YORK (PRWEB) , ... July 07, 2020 , ... ... in public health. The COVID-19 pandemic thrust this field into the spotlight ... percent for public health careers by 2026. In partnership with South University ...
(Date:7/7/2020)... ... 2020 , ... Great Point Partners (“GPP”) today announced that the Spine & ... Katz as Vice President of Business Development. , "After a comprehensive search process, ... role for the organization," said Adam Elberg, chairman of the Spine & Sport board ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , Future ... trends, news, and products within specific scientific niches. Since their launch four years ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... with memory impairment, has announced the Best Memory Care Facilities in Charleston, South ... experts, facility features and amenities. , According to the Alzheimer’s Association ...
(Date:7/2/2020)... ... ... Dr. Christine Blaine has earned a stellar reputation as one ... Staten Island, Huntington and NYC, NY. Her former Manhattan clinic, located at 1201 ... Parlor NYC at 160 Madison Avenue. Blaine Plastic Surgery will be one ...
Breaking Medicine News(10 mins):